American Exceptionalism flags going-concern warning
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
American Exceptionalism Acquisition Corp. A (AEXA) reported net income of $2,794,869 for the three months ended September 30, 2026, as $3,239,568 of Trust Account interest exceeded $444,699 of general and administrative expense. Nine-month net income was $8,528,589, reflecting $9,413,379 of trust interest and $884,790 of general and administrative expense. AEXA has generated no operating revenue and expects none before a business combination.
As of September 30, 2026, AEXA had not selected a target or held substantive target discussions. Its Trust Account held $357,779,541 in marketable securities; cash outside the account was $97,843, and its working capital deficit was $103,529. Management determined that the liquidity condition and mandatory liquidation if no business combination is completed raise substantial doubt about the company’s ability to continue as a going concern within one year after the statements were issued. The business-combination deadline is September 29, 2027, extendable to December 29, 2027 if AEXA executes a letter of intent, agreement in principle or definitive agreement within 24 months after the IPO.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointGoing-concern uncertainty alongside $97,843 operating cash and a September 2027 liquidation deadline.
Filing Explained
Closing a business combination makes the $10.35 million advisory and deferred underwriting fees payable; deal-related share issuance can materially dilute public holders through founder-share conversion.
The report lists an advisory-fee liability of
If additional shares or equity-linked securities are issued or deemed issued for a business-combination closing, the Class B conversion ratio adjusts—unless a majority of Class B holders waives the adjustment—so shares issuable on conversion equal
In plain terms, issuing additional shares increases the total share count and reduces an existing holder’s percentage ownership, absent offsetting changes.
Key Figures
Key Terms
substantial doubt financial
temporary equity technical
Trust Account financial
deferred underwriting discount financial
working capital deficit financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much net income did AEXA report for the third quarter of 2026?
How much did AEXA hold in its Trust Account?
What redemption value per AEXA public share was reported for September 30, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
CA |
||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| Page | ||||
| Part I. Financial Information |
||||
| Item 1. Interim Financial Statements |
||||
| Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 |
1 | |||
| Condensed Statements of Operations for the three and nine months ended September 30, 2026 (Unaudited) and for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited) |
2 | |||
| Condensed Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2026 (Unaudited) and for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited) |
3 | |||
| Condensed Statements of Cash Flows for the nine months ended September 30, 2026 (Unaudited) and for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited) |
4 | |||
| Notes to Condensed Financial Statements (Unaudited) |
5 | |||
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
17 | |||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk |
19 | |||
| Item 4. Controls and Procedures |
19 | |||
| Part II. Other Information |
||||
| Item 1. Legal Proceedings |
20 | |||
| Item 1A. Risk Factors |
20 | |||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
20 | |||
| Item 3. Defaults Upon Senior Securities |
20 | |||
| Item 4. Mine Safety Disclosures |
20 | |||
| Item 5. Other Information |
20 | |||
| Item 6. Exhibits |
21 | |||
| Signatures |
22 | |||
i
September 30, 2026 (Unaudited) |
December 31, 2025 |
|||||||
Assets: |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Due from Sponsor |
||||||||
Prepaid expenses |
||||||||
Total current assets |
||||||||
Long-term prepaid insurance |
||||||||
Marketable securities held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
Total current liabilities |
||||||||
Advisory fee payable |
||||||||
Deferred underwriting fee payable |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A Ordinary Shares subject to possible redemption, $ |
||||||||
Shareholders’ Deficit |
||||||||
Preference shares, $ |
||||||||
Class A Ordinary Shares, $ |
||||||||
Class B Ordinary Shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
$ |
$ |
||||||
| (1) | On September 25, 2 per-share amounts have been retroactively presented (see Note 5). |
| (2) | Includes i ts over-allotment option in full as part of the closing of the Initial Public Offering, as defined below. As such, the |
For the Three Months Ended September 30, 2026 |
For the Nine Months Ended September 30, 2026 |
For the Period from July 11, 2025 (Inception) Through September 30, 2025 |
||||||||||
Advisory fee expense |
$ | $ | $ | |||||||||
General and administrative expenses |
||||||||||||
Loss from operations |
( |
) |
( |
) |
( |
) | ||||||
Other income: |
||||||||||||
Interest earned on marketable securities held in Trust Account |
||||||||||||
Total other income |
||||||||||||
Net income (loss) |
$ |
$ |
$ |
( |
) | |||||||
Weighted average shares outstanding of Class A Ordinary Shares, basic and diluted |
||||||||||||
Basic and diluted net income (loss) per ordinary share, Class A Ordinary Shares |
$ |
$ |
$ |
( |
) | |||||||
Weighted average shares outstanding of Class B Ordinary Shares, basic and diluted(1)(2) |
||||||||||||
Basic and diluted net income (loss) per ordinary share, Class B Ordinary Shares |
$ |
$ |
$ |
( |
) | |||||||
| (1) | On September 25, 2025, the Company issued an additional shares to the Sponsor through share capitalization. As a result, the Sponsor holds an aggregate of per-share amounts have been retroactively presented (see Note 5). |
| (2) | Includes i ts over-allotment option in full as part of the closing of the Initial Public Offering. As such, the |
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares(1)(2) |
Amount |
|||||||||||||||||||||||||
| Balance – January 1, 2026 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Accretion for Class A Ordinary Shares to redemption amount |
— | — | — | — | — |
( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2026 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Accretion for Class A Ordinary Shares to redemption amount |
— | — | — | — | — |
( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – June 30, 2026 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Accretion for Class A Ordinary Shares to redemption amount |
— | — | — | — | — |
( |
) | ( |
) | |||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2026 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares(1)(2) |
Amount |
|||||||||||||||||||||||||
| Balance — July 11, 2025 (Inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
| Issuance of Class B ordinary shares to Sponsor |
— | — | — | |||||||||||||||||||||||||
| Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Sale of |
— | — | — | |||||||||||||||||||||||||
| Allocated value of transaction costs to Private Placement Shares |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2025 (Unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) | On September 25, 2025, the Company issued an additional per-share amounts have been retroactively presented (see Note 5). |
| (2) | Includes |
For the Nine Months Ended September 30, 2026 |
For the Period from July 11, 2025 (Inception) Through September 30, 2025 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
||||||||
Payment of operating costs through promissory note – related party |
||||||||
Interest earned on marketable securities held in Trust Account |
( |
) | ( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ( |
) | ||||
Long-term prepaid insurance |
( |
) | ||||||
Accrued expenses |
||||||||
Advisory fee payable |
||||||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash in Trust Account |
( |
) | ||||||
Net cash used in investing activities |
( |
) | ||||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Shares, net of underwriting discounts paid |
||||||||
Proceeds from sale of Private Shares |
||||||||
Proceeds from promissory note – related party |
||||||||
Due from Sponsor |
( |
) | ||||||
Payment of offering costs |
( |
) | ( |
) | ||||
Net cash (used in) provided by financing activities |
( |
) |
||||||
Net Change in Cash |
( |
) |
||||||
Cash – Beginning of period |
||||||||
Cash – End of period |
$ |
$ |
||||||
Noncash investing and financing activities: |
||||||||
Offering costs included in accrued offering costs |
$ | $ | ||||||
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
$ | $ | ||||||
Deferred underwriting fee payable |
$ | $ | ||||||
| For the Three Months Ended September 30, 2026 (Unaudited) |
For the Nine Months Ended September 30, 2026 (Unaudited) |
For the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited) |
||||||||||||||||||||||
| Class A | Class B | Class A | Class B | Class A | Class B | |||||||||||||||||||
| Basic and diluted net income (loss) per share: |
||||||||||||||||||||||||
| Numerator: |
||||||||||||||||||||||||
| Allocation of net income (loss), basic and diluted |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||
| Denominator: |
||||||||||||||||||||||||
| Basic and diluted weighted-average ordinary shares outstanding |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net income (loss) per ordinary share |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Class A Ordinary Shares issuance cost |
( |
) | ||
| Plus: |
||||
| Remeasurement of carrying value to redemption value |
||||
| |
|
|||
| Class A Ordinary Shares subject to possible redemption, December 31, 2025 |
$ | |||
| Plus: |
||||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A Ordinary Shares subject to possible redemption, March 31, 2026 |
$ | |||
| Plus: |
||||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A Ordinary Shares subject to possible redemption, June 30, 2026 |
$ | |||
| Plus: |
||||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A Ordinary Shares subject to possible redemption, September 30, 2026 |
$ | |||
| |
|
| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| Level 3: | Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. | |
| Level | September 30, 2026 |
December 31, 2025 |
||||||||||
| Marketable securities held in Trust Account |
1 | $ | $ | |||||||||
| For the Three Months Ended September 30, 2026 |
For the Nine Months Ended September 30, 2026 |
For the Period from July 11, 2025 (Inception) Through September 30, 2025 |
||||||||||
| General and administrative expenses |
$ | $ | $ | |||||||||
| Interest earned on marketable securities held in Trust Account |
$ | $ | $ | |||||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to AMERICAN EXCEPTIONALISM ACQUISITION CORP. A. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to AEXA Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in the Cayman Islands on July 11, 2025 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of our initial public offering (the “Initial Public Offering”) and the sale of the private placement shares, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete our Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from July 11, 2025 (inception) through September 30, 2026, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for our Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial Public Offering, we generate non-operating income in the form of interest income on marketable securities held in our trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2026, we had a net income of $2,794,869, which consisted of interest earned on marketable securities held in our trust account of $3,239,568 offset by general and administrative costs of $444,699.
For the nine months ended September 30, 2026, we had a net income of $8,528,589, which consisted of interest earned on marketable securities held in our trust account of $9,413,379 offset by general and administrative costs of $884,790.
For the period from July 11, 2025 (inception) through September 30, 2025, we had a net loss of $10,423,509, which consisted of advisory fee expense of $10,350,000 and general and administrative costs of $111,169, partially offset by Interest earned on marketable securities held in trust Account of $37,660.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B Ordinary Shares, par value $0.0001 per share, by the Sponsor and loans from the Sponsor.
17
On September 29, 2025, we consummated our Initial Public Offering of 34,500,000 Class A Ordinary Shares, which includes the full exercise by the underwriter of its over-allotment option in the amount of 4,500,000 Class A Ordinary Shares, at $10.00 per share, generating gross proceeds of $345,000,000. Simultaneously with the closing of our Initial Public Offering, we consummated the sale of 175,000 private placement shares, at a price of $10.00 per private placement share in a private placement to the Sponsor, generating gross proceeds of $1,750,000.
Following our Initial Public Offering, the full exercise of the over-allotment option, and the sale of the shares, a total of $345,000,000 was placed in the trust account. We incurred $11,130,322, consisting of $250,000 of cash underwriting fee, $10,350,000 of deferred underwriting fee, and $530,322 of other offering costs.
For the nine months ended September 30, 2026, net cash used in operating activities was $341,392. This amount reflects net income of $8,528,589, adjusted for interest earned on marketable securities held in the Trust Account of $9,413,379 and changes in operating assets and liabilities of $543,398.
For the period from July 11, 2025 (inception) through September 30, 2025, net cash used in operating activities was $320,647. This amount primarily reflects a net loss of $10,423,509, partially offset by interest income of $37,660, general and administrative costs paid through a related party promissory note of $22,830, formation costs of $8,488 paid by the Sponsor in exchange for Class B ordinary shares, and changes in operating assets and liabilities of $10,109,204.
As of September 30, 2026, we had investments held in our trust account of $357,779,541 (including $12,779,541 of interest income) consisting of investments in money market funds that invest in U.S. Treasury securities and comply with Rule 2a-7 under the Investment Company Act. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2026, we had cash of $97,843 outside our trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such working capital loans may be converted into private placement shares upon consummation of the Business Combination at a price of $10.00 per share. The shares would be identical to the private placement shares.
If our estimate of the costs of identifying a target business, undertaking in-depth due diligence, and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. As of September 30, 2026, we had a working capital deficit of $103,529. In connection with our assessment of going concern considerations in accordance with ASC 205-40, management has determined that the liquidity condition and the mandatory liquidation, should a Business Combination not be consummated by September 29, 2027, and potential subsequent dissolution raise substantial doubt about our ability to continue as a going concern within one year after the date these financial statements are issued.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
18
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the following. The underwriter is entitled to a deferred underwriting fee of $10,350,000, which will become payable from the amounts held in the Trust Account solely in the event that we complete our initial Business Combination, subject to the terms of the underwriting agreement. In addition, the underwriter is entitled to an advisory fee of $10,350,000, equal to 3% of the gross proceeds of the Initial Public Offering, which has been recorded as a liability. Pursuant to the advisory agreement, the advisory fee was deemed earned and recordable as of September 29, 2025, and is payable upon and subject to the closing of our initial Business Combination.
The underwriter was entitled to an underwriting discount of $250,000 which was paid in cash upon the closing of the Initial Public Offering.
The Company entered into an agreement with the underwriter in which the underwriter is entitled to an advisory fee equal to 3% of the gross proceeds raised in the Initial Public Offering upon and subject to the closing of the initial Business Combination.
Critical Accounting Estimates and Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of September 30, 2026, we did not have any critical accounting estimates to be disclosed.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our Management, including the Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, the Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended September 30, 2026.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2026 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
19
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| No. | Description of Exhibit | |
| 10.1 | Joinder to the Letter Agreement, dated September 1, 2026, between the Company and Mr. Teng (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on September 4, 2026). | |
| 10.2 | Letter Agreement, dated as of September 25, 2025, among the Company, the Sponsor and the Company’s officers and directors (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on September 29, 2025). | |
| 10.3 | Joinder to the Registration Rights Agreement, dated September 1, 2026, between the Company and Mr. Teng (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed with the SEC on September 4, 2026). | |
| 10.4 | Registration Rights Agreement, dated as of September 25, 2025, among the Company, the Sponsor and certain other security holders named therein (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed with the SEC on September 29, 2025). | |
| 10.5 | Form of Indemnity Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed with the SEC on September 29, 2025). | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS | Inline XBRL Instance Document. | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |
| * | Filed herewith. |
| ** | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
21
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMERICAN EXCEPTIONALISM ACQUISITION CORP. A | ||||||
| Date: November 13, 2026 | By: | /s/ Steven Trieu | ||||
| Name: | Steven Trieu | |||||
| Title: | Chief Executive Officer | |||||
| (Principal Executive Officer) | ||||||
| Date: November 13, 2026 | By: | /s/ Jeffrey Vignos | ||||
| Name: | Jeffrey Vignos | |||||
| Title: | Chief Financial Officer | |||||
| (Principal Financial Officer and Accounting Officer) | ||||||
22